Azenta, Inc.
NASDAQAzenta has just delivered its fiscal Q3 earnings — the setup heading into the print was as charged as any in the life sciences tools space this week, and the reaction over the next session will determine whether the stock's month-long recovery holds or reverses sharply. The price action tells an encouraging story heading in. AZTA closed at $30.13, up 4.1% on the week and 16.6% over…
Snapshot as of 6 Aug 2026
Azenta has just delivered its fiscal Q3 earnings — the setup heading into the print was as charged as any in the life sciences tools space this week, and the reaction over the next session will determine whether the…
AZTA reports fiscal Q3 results today against a backdrop that is genuinely uncomfortable: a heavily shorted stock that collapsed after its last earnings release, now trading back near where insiders last sold — a setup…
Azenta enters the post-earnings week with one of the sharpest short-interest buildups in its recent history — and the stock has barely flinched. Short sellers have been piling into AZTA at a pace that stands out even…
Azenta, Inc. heads into its Q2 FY2026 earnings print on May 6 with one of the most aggressive short-interest buildups in the life sciences tools space. Shorts have done most of the work in April. SI as a percentage of…
Azenta heads into its May 5 earnings call carrying the heaviest short interest it has seen in months, a building bearish footprint that arrived just as the stock broke back down from a sharp one-month rally. Short…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for AZTA — free to start on ORTEX.
Sign up for free →Open AZTA on ORTEX